Companies in the cannabis sector have the potential to increase your wealth at an enviable rate over the upcoming decade. While the cannabis sector continues to remain volatile, we like cannabis stocks like Columbia Care – but why should you consider this cannabis stock?
The recent wave of cannabis legalization sweeping through the U.S. along with the prospect of decriminalizing or even legalizing adult-use will be key drivers for licensed producers.
Related: Columbia Care Announces Launch of West Virginia Market Operations
Here, we take a look at Columbia Care. This cannabis stock should certainly be on your radar right now. Yes, this cannabis stock is also trading at a deep discount according to Wall Street estimates, allowing investors to derive multi-bagger gains in the next 12 months. But why should you consider this cannabis stock?
Columbia Care: Why Should You Consider Cannabis Stock
U.S.-based multi-state operator, Columbia Care (OTC: CCHWF) is valued at a market cap of $1.12 billion. The company has already increased revenue from $77.4 million in 2019 to $179 million last year.
Now, Wall Street expects sales to more than triple year over year to $625 million in 2021 and surpass $970 million next year. These stellar growth rates in revenue should allow Columbia Care to improve its bottom-line. Columbia Care’s bottom line should theoretically improve from a loss per share of $0.48 in 2020 to earnings per share of $0.3.
Columbia Care has a presence in 18 jurisdictions across the U.S. and Europe, where it operates 31 cultivation and manufacturing facilities.
Related: Columbia Care: Is this Cannabis Stock a Buy?
The company generated $110 million in revenue in Q2 which was 232% higher than the prior-year period. Yes, Columbia Care has 73 active dispensaries but they have another 26 under development. This enables the company to target a rapidly expanding addressable market that is forecast to reach $31.6 billion by 2026.
Analysts tracking Columbia Care stock have a 12-month average price target of $9.38 for the stock which is about 3x higher than its current trading price as of November 7th, 2021.
For these reasons, we believe you should consider taking a position in Columbia Care.
Columbia Care: Why Should You Consider Cannabis Stock?
About Cannin: Your Cannabis Stocks Resource
78% of Cannin’s fundamentals prove true within 30 days or less on 100+ recommendations over the past 2 years.
Cannin is your #1 trusted resource for cannabis stocks. Our global team of experts evaluates all emerging cannabis stock investing opportunities. In fact, we aggregate hundreds of hours of financial research and provide tips on the best cannabis stocks for 2021.
Use Cannin as your resource for:
In fact, market analysts expect the marijuana and hemp industry will have an annual value exceeding $75 Billion in the next decade. Is it too late to invest in marijuana stocks? No! This is the perfect time to invest.
Are you looking to buy stock in hemp companies or marijuana companies for 2021? If so, are you interested in new penny hemp stock companies? Or, looking for the best Canadian cannabis stocks to invest in? Maybe, you’re looking to leverage the power of algorithmic stock trading to beat the cannabis market? If you’re interested, we can help.
Are you interested in cannabis stocks like Curaleaf, Trulieve, Aurora Cannabis, Charlotte’s Web, Canopy Growth, or Hemp Inc.?
Predict price movements of cannabis stocks several hours in advance with our proprietary algorithmic stock trading software.
- +30% Gains in 2020
- +49.8% Gains in 2019
- Backtested since 2012
In fact, we’re so confident you’ll love our algotrading cannabis stock signals, we’re willing to give you a one week risk-free trial to see it for yourself.
Profit from the best cannabis stocks – we’ll show you how at cannin.com.